Iressa 250mg 30s 250mg Tablet

Iressa 250mg 30s

Active Ingredient:
Gefitinib
Form:
Tablet
Brand:
Iressa
Origin:
Australia

Buy Iressa 250mg 30s Gefitinib

Iressa 250mg 30s (Gefitinib) is an oral tablet used to treat certain types of non-small cell lung cancer. This targeted therapy helps slow cancer progression by blocking specific signals in cancer cells. Suitable for patients with EGFR mutations, it is available in a 30-tablet pack.

Strength

250mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Apotex

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Gefitinib is primarily used to treat non-small cell lung cancer (NSCLC) in patients with epidermal growth factor receptor (EGFR) mutations. It may be prescribed for advanced or metastatic lung cancer when other treatments are not suitable. This medication works by targeting specific proteins in cancer cells to slow their growth. It is not a first-line treatment for all lung cancer cases.

Side Effects

  • Common effects of Gefitinib include mild nausea, diarrhea, and skin reactions such as rash or dryness. Some patients may experience fatigue or loss of appetite. These effects are generally manageable and often temporary. Regular monitoring by a healthcare provider is recommended to assess response and adjust care as needed.

Precautions & Warnings

  • Gefitinib should be taken exactly as prescribed, typically once daily on an empty stomach. Patients should inform their doctor about all medications, including over-the-counter drugs and supplements. Regular liver function tests may be required during treatment. Avoid grapefruit products as they may interact with Gefitinib.

Avoid Interactions

  • Gefitinib can interact with certain medications, including strong CYP3A4 inhibitors or inducers, which may affect its effectiveness. Blood thinners, antacids, and some herbal supplements may also interact. Alcohol use should be discussed with a healthcare provider. Always consult a doctor before combining Gefitinib with other drugs.

References

Frequently Asked Questions

Gefitinib is used to treat non-small cell lung cancer (NSCLC) in patients with specific EGFR mutations.

Gefitinib is taken orally once daily, usually on an empty stomach. Follow your doctor's instructions for the best results.

Common side effects include rash, diarrhea, nausea, and fatigue. Most effects are mild and temporary.

Alcohol use should be discussed with your doctor, as it may interact with Gefitinib or worsen side effects.

No, Gefitinib is a targeted therapy that blocks specific signals in cancer cells rather than killing all rapidly dividing cells.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT